GHRP-6 is the GHRP most associated with a strong appetite effect, which is its
most distinctive characteristic relative to the rest of the family.
Chemical identity & structure.
GHRP-6 (growth hormone releasing peptide-6) is a synthetic hexapeptide and one
of the earliest-characterized members of the GHRP family. It is a ghrelin
mimetic — a GHS-R agonist — not a GHRH analog.
Mechanism of action.
GHRP-6 agonizes the GHS-R to stimulate a pituitary growth hormone pulse. Its
most pronounced distinguishing feature is a strong appetite-stimulating effect:
because ghrelin is the body's hunger signal, GHRP-6's ghrelin mimicry produces
notable hunger. It is also reported to raise cortisol and prolactin modestly.
Like the other GHRPs it is studied in combination with GHRH analogs for a larger
combined GH pulse.
Key research findings.
GHRP-6 has been used extensively as a research tool to probe the GHS-R/ghrelin
system, and was important historically in the discovery of that receptor and
its natural ligand. The literature documents GH-release stimulation and the
characteristic appetite effect.
The research / citation base.
GHRP-6 is not an approved drug. Its main significance is as a research tool
in the pharmacology that led to the identification of ghrelin and the GHS-R; its
evidence base is preclinical and clinical-pharmacology research, not
efficacy-outcome trials.
Human clinical trial data.
In a phase I pharmacokinetic study by Cabrales et al. (2012), nine male healthy volunteers received a single intravenous bolus of 100, 200 and 400 μg/kg of body weight (PubMed). The appetite effect is a consistent observation in the literature.
Quality & sourcing notes.
A batch-specific COA with mass-spectrometry identity and HPLC purity is the
minimum bar; confirm the COA describes GHRP-6 specifically given how similar the
GHRP peptides are.
*Research-use note: Educational summary of published research. GHRP-6 is not an
approved drug; this is research context only and not medical advice.*
